Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check this out.. https://biogenx-sandbox.myshopify.com/products/vitastem?variant=34522209648803
$VDRM $$$
Agreed! Honestly looked like a few shorts covering at the end of the day because VDRM held up really really WELL considering being up almost 1500% yesterday
Great things ahead for $VDRM $$$$
Looks like shorts are covering because they know what's coming!
$VDRM $$$
Crazy THIN.. all the way to .09
Starting to move up again.. Here we go!
Exactly! Stair steps to .10, then .25 etc etc..
14 steps up yesterday
Taking a breather today
Friday we go up 1
Next week some more..
Come on people!
$VDRM $$$$
True HorizenBull! Hang tight, they are coming..
PokerStar! How are you buddy?! Yes I agree! $VDRM
Just buy and hold this! Wait until names/financials are released
$VDRM $$$$
2021 will be $VDRM's year!!
I spoke with the company.. names of companies/hospitals are coming.. buy what you can, this will be an amazing hold! That's all I'm going to say ;)
$VDRM $$$
.04+ close
$VDRM $$$
Time to LOAD UP!!! Watch this reverse hard! $VDRM $$$$
A little dip, then we head back over .05+ into the close
$VDRM $$$
.25+ will be here in a week or two...
$VDRM $$$
Almost 400MILLION already!
$VDRM $$$
Wow!! Blowing up on Twitter! $VDRM
https://twitter.com/search?q=%24VDRM&src=cashtag_click&f=live
Just wait once the financials come out and the company/hospital names/contracts are released!!! This could very well run for months!
$VDRM $$$$$
VDRM Stock: 13 Things to Know as Penny Stock ViaDerma Rockets 1,000%
VDRM shares are skyrocketing today. Here's what you should know.
By Sarah Smith, InvestorPlace Web Content Producer Jan 13, 2021, 4:06 pm EST
Shares of ViaDerma (OTCMKTS:VDRM) gained nearly 1,000% nearing market close Wednesday, after the pharmaceutical company released its review of 2020 and outlook for 2021. VDRM stock typically flies under the radar, so many investors may not be familiar with the high-flying name. With that in mind, what should you know about this penny stock news now?
Image of a penny held between two fingers with a white indoor background
Source: Shutterstock
To start, investors should know that ViaDerma is a specialty pharmaceutical company that trades over the counter. This is one reason VDRM stock is less familiar, in addition to its penny-stock status.
Considering this, here is what you need to know about ViaDerma and VDRM stock now:
ViaDerma has been around since 2014, thanks to the founding of Dr. Christopher Otiko.
The company calls Marina Del Ray, California its home.
So what does the company do? Primarily, ViaDerma develops and markets pharmaceutical products.
However, the company also licenses its technology to others in the industry.
Right now, its leading product is Vitastem.
This product is a tetracycline-based topical antibiotic.
Patients can use Vitastem for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema and a variety of minor injuries.
According to the company, Vitastem is distinct because it treats so many different conditions.
Additionally, Vitastem is available for public use and has been registered with the U.S. Food and Drug Administration.
Another thing that stands out about Vitastem is that it allows pharmaceutical companies to apply different active drugs in a topical format.
This means ViaDerma can license the transdermal delivery method of Vitastem to others in the industry.
Investors should note that ViaDerma is targeting several large markets.
For instance, the company estimates that the market for topical antibiotics alone is $6 billion a year.
The Bottom Line on VDRM Stock
So what should you do with ViaDerma and VDRM stock? And why are shares soaring on Wednesday?
The upside move is likely because of the company outlook for 2021. In the release, ViaDerma acknowledged that 2020 was a strong year. It launched a new pain relief product, secured further financing and saw large-scale potential clients test its signature Vitastem.
Looking to 2021 then, that means there is a chance for ViaDerma to capitalize on its successes from 2020 and carve out even more gains. However, as with any penny stock, and particularly those in the biopharma space, tread carefully. As quickly as the stock runs up, the next minute those gains could be gone.
On the date of publication, Sarah Smith did not have (either directly or indirectly) any positions in the securities mentioned in this article.
Sarah Smith is a Web Content Producer with InvestorPlace.com.
100% AGREE!! $VDRM
OMG Grandma!
You're ALIVE!!! LOL
Thought you got kicked out of Ma's basement again!
BAHAHAHAHA
Should be real time .. always has been in the past!
That's why this is NOT Ihub $ coming in.. cuz no one here knows expect people on this board
Crying his his Gramma's basement! LMFAO!!!
ummm maybe we will see .05+ in the AM!!!
$VDRM
2021 is FINALLY the year for $VDRM $$$$$$
LOL.. I've never left.. always been here.. and yes .25+ coming!!
This time it will happen ;)
.25+ coming!!!!! Lets go $VDRM $$$$